Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndrome

Keyphrases

• End-stage Renal Disease Patients 100%
• Antiphospholipid Antibody Syndrome 100%
• Anticoagulant Therapy 100%
• Coumadin 75%
• Heparin 50%
• Bleeding Complications 50%
• Allograft Loss 50%
• Patient Demographics 25%
• High Risk 25%
• Clinical High Risk 25%
• Renal Transplant Recipients 25%
• Dialysis 25%
• Renal Thrombosis 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Syndrome 100%
• Antiphospholipid Antibody 100%
• End Stage Renal Disease 100%
• Anticoagulation Therapy 100%
• Warfarin 75%
• Bleeding 50%
• Heparin 50%
• Side Effect 25%
• Thrombosis 25%
• Crush Syndrome 25%

Medicine and Dentistry

• Antiphospholipid Antibody 100%
• End Stage Renal Disease 100%
• Anticoagulant Therapy 100%
• Warfarin 75%
• Bleeding 50%
• Allograft 50%
• Heparin 50%
• Patient Population 25%
• Side Effect 25%
• Thrombosis 25%
• Kidney Graft 25%